Eight macrocyclic peptides designed to bind Holliday junctions (DNA recombination intermediates) in bacteria showed antibacterial activity, introducing an entirely new antibiotic mechanism targeting bacterial DNA repair.
Brand new mechanismThese macrocyclic peptides target bacterial DNA junctions — a mechanism no existing antibiotic uses, meaning no pre-existing resistance exists
What the researchers found
Macrocyclic peptides designed to bind Holliday DNA junctions showed antibacterial activity, validating a completely novel antibiotic mechanism targeting bacterial DNA repair/recombination.
Why it matters
A completely new antibiotic mechanism — targeting DNA junctions — gives bacteria no pre-existing resistance. Novel mechanisms are desperately needed as existing antibiotic classes fail.
How the study worked
In-vitro study. Eight macrocyclic peptides designed computationally to bind Holliday junction DNA structures. Synthesized and tested for antibacterial activity against bacterial cultures.
What this study cannot tell us
Short abstract with limited potency data. In-vivo efficacy unknown. Selectivity for bacterial versus human DNA junctions needs confirmation.
How to read the evidence
Preliminary in-vitro proof-of-concept with novel mechanism validation, limited by early-stage development.
When this study was published
Published in 2003. DNA-targeting antimicrobial strategies continue to be explored as novel antibiotic approaches.
The bigger picture
Every new antibiotic mechanism represents a new weapon against resistance. Targeting DNA recombination is fundamentally different from membrane disruption, ribosome inhibition, or cell wall synthesis — the targets of existing antibiotics.
Questions still open
- Do these peptides selectively target bacterial Holliday junctions?
- Can the potency be improved through structural optimization?
- Would bacteria develop resistance to DNA junction trapping?
Common questions
How are these different from other antibiotics?
Could bacteria resist this?
Read the original research
Novel antibiotics: macrocyclic peptides designed to trap Holliday junctions.
Organic letters, 5(2), 109-12
Citation
Bolla, Megan L; Azevedo, Enrique V; Smith, Jason M; Taylor, Rachel E; Ranjit, Dev K; Segall, Anca M; McAlpine, Shelli R. (2003). Novel antibiotics: macrocyclic peptides designed to trap Holliday junctions.. Organic letters, 5(2), 109-12.